FDANonrulemakingFDA-2025-D-5107

Who commented on this docket

Menstrual Products - Labeling and Performance Testing Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

1 organizations filed 1 public comment on Menstrual Products - Labeling and Performance Testing Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability, at the Food and Drug Administration. The comment window closed 193d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 193d ago

Abstract

Open

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.